Cite Filings / AVTX / 0000919574-21-000244
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Avalo Therapeutics, Inc. · Filed 2021-01-12 · Acc 0000919574-21-000244

Documents 1

  • SC 13D/A Beneficial Ownership Report , d8720113_13d-a.htm

Around this filing

  • 2021-09-17 SC 13D/A Beneficial Ownership Report
  • 2021-01-12 4 Director bought 2,500,000 shares at $2.60 ($6,500,000)
  • 2021-01-12 SC 13D/A Beneficial Ownership Report
  • 2021-01-08 8-K Material agreement · Other events
  • 2021-01-08 424B5 Prospectus
  • 2021-01-07 424B5 Prospectus
  • 2020-07-31 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · BVF PARTNERS L P/IL 1.7%
  2. 2026-11-16 SCHEDULE 13G/A · Point72 Asset Management, L.P. 3.0%
  3. 2026-11-13 SCHEDULE 13G · Farallon Capital Management, L.L.C. 7.4%
Loading d8720113_13d-a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…